Logo image of AUTL

AUTOLUS THERAPEUTICS PLC (AUTL) Stock Fundamental Analysis

USA - NASDAQ:AUTL - US05280R1005 - ADR

1.53 USD
+0.03 (+2%)
Last: 10/24/2025, 8:09:53 PM
1.5595 USD
+0.03 (+1.93%)
After Hours: 10/24/2025, 8:09:53 PM
Fundamental Rating

3

AUTL gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 534 industry peers in the Biotechnology industry. AUTL scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. AUTL is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

AUTL had negative earnings in the past year.
AUTL had a negative operating cash flow in the past year.
In the past 5 years AUTL always reported negative net income.
In the past 5 years AUTL always reported negative operating cash flow.
AUTL Yearly Net Income VS EBIT VS OCF VS FCFAUTL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50M -100M -150M -200M

1.2 Ratios

The Return On Assets of AUTL (-31.59%) is better than 65.92% of its industry peers.
With a Return On Equity value of -65.74%, AUTL perfoms like the industry average, outperforming 59.18% of the companies in the same industry.
Industry RankSector Rank
ROA -31.59%
ROE -65.74%
ROIC N/A
ROA(3y)-38.02%
ROA(5y)-39.48%
ROE(3y)-96.13%
ROE(5y)-80.28%
ROIC(3y)N/A
ROIC(5y)N/A
AUTL Yearly ROA, ROE, ROICAUTL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150

1.3 Margins

AUTL does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AUTL Yearly Profit, Operating, Gross MarginsAUTL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 -2K -4K -6K -8K -10K

More info and screens

4

2. Health

2.1 Basic Checks

AUTL does not have a ROIC to compare to the WACC, probably because it is not profitable.
The debt/assets ratio for AUTL has been reduced compared to a year ago.
AUTL Yearly Shares OutstandingAUTL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M
AUTL Yearly Total Debt VS Total AssetsAUTL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

Based on the Altman-Z score of -2.06, we must say that AUTL is in the distress zone and has some risk of bankruptcy.
AUTL has a Altman-Z score of -2.06. This is comparable to the rest of the industry: AUTL outperforms 50.00% of its industry peers.
AUTL has a Debt/Equity ratio of 0.71. This is a neutral value indicating AUTL is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.71, AUTL is not doing good in the industry: 73.78% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF N/A
Altman-Z -2.06
ROIC/WACCN/A
WACC7.86%
AUTL Yearly LT Debt VS Equity VS FCFAUTL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

2.3 Liquidity

A Current Ratio of 8.43 indicates that AUTL has no problem at all paying its short term obligations.
AUTL's Current ratio of 8.43 is fine compared to the rest of the industry. AUTL outperforms 75.28% of its industry peers.
A Quick Ratio of 8.07 indicates that AUTL has no problem at all paying its short term obligations.
With a decent Quick ratio value of 8.07, AUTL is doing good in the industry, outperforming 73.97% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 8.43
Quick Ratio 8.07
AUTL Yearly Current Assets VS Current LiabilitesAUTL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

8

3. Growth

3.1 Past

AUTL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 27.35%, which is quite impressive.
AUTL shows a strong growth in Revenue. In the last year, the Revenue has grown by 496.00%.
The Revenue has been growing by 28.31% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)27.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%18.18%
Revenue 1Y (TTM)496%
Revenue growth 3Y63.16%
Revenue growth 5Y28.31%
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, AUTL will show a very strong growth in Earnings Per Share. The EPS will grow by 20.32% on average per year.
AUTL is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 122.11% yearly.
EPS Next Y-1.36%
EPS Next 2Y9.4%
EPS Next 3Y15.01%
EPS Next 5Y20.32%
Revenue Next Year481.22%
Revenue Next 2Y248.71%
Revenue Next 3Y180.05%
Revenue Next 5Y122.11%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
AUTL Yearly Revenue VS EstimatesAUTL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M 1B
AUTL Yearly EPS VS EstimatesAUTL Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 1 -1 -2

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

AUTL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AUTL. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AUTL Price Earnings VS Forward Price EarningsAUTL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AUTL Per share dataAUTL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 -1

4.3 Compensation for Growth

A more expensive valuation may be justified as AUTL's earnings are expected to grow with 15.01% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y9.4%
EPS Next 3Y15.01%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for AUTL!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AUTOLUS THERAPEUTICS PLC

NASDAQ:AUTL (10/24/2025, 8:09:53 PM)

After market: 1.5595 +0.03 (+1.93%)

1.53

+0.03 (+2%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)08-12 2025-08-12/bmo
Earnings (Next)11-10 2025-11-10/bmo
Inst Owners82.36%
Inst Owner Change-0.22%
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap407.20M
Revenue(TTM)29.93M
Net Income(TTM)-227778000
Analysts85.88
Price Target9.65 (530.72%)
Short Float %5.38%
Short Ratio2.86
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)11.59%
Min EPS beat(2)-1.96%
Max EPS beat(2)25.13%
EPS beat(4)2
Avg EPS beat(4)8.42%
Min EPS beat(4)-41.83%
Max EPS beat(4)52.34%
EPS beat(8)2
Avg EPS beat(8)-47.73%
EPS beat(12)5
Avg EPS beat(12)-30.26%
EPS beat(16)7
Avg EPS beat(16)-22.09%
Revenue beat(2)2
Avg Revenue beat(2)192.72%
Min Revenue beat(2)58.95%
Max Revenue beat(2)326.5%
Revenue beat(4)2
Avg Revenue beat(4)46.6%
Min Revenue beat(4)-100%
Max Revenue beat(4)326.5%
Revenue beat(8)2
Avg Revenue beat(8)-10.6%
Revenue beat(12)5
Avg Revenue beat(12)142.7%
Revenue beat(16)5
Avg Revenue beat(16)97.23%
PT rev (1m)0%
PT rev (3m)-2.17%
EPS NQ rev (1m)1.87%
EPS NQ rev (3m)3.09%
EPS NY rev (1m)1.02%
EPS NY rev (3m)5.2%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)28.08%
Revenue NY rev (1m)0%
Revenue NY rev (3m)29.85%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 13.6
P/FCF N/A
P/OCF N/A
P/B 1.18
P/tB 1.22
EV/EBITDA N/A
EPS(TTM)-0.85
EYN/A
EPS(NY)-0.7
Fwd EYN/A
FCF(TTM)-1.17
FCFYN/A
OCF(TTM)-0.99
OCFYN/A
SpS0.11
BVpS1.3
TBVpS1.25
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -31.59%
ROE -65.74%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-38.02%
ROA(5y)-39.48%
ROE(3y)-96.13%
ROE(5y)-80.28%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 565.42%
Cap/Sales 163.58%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 8.43
Quick Ratio 8.07
Altman-Z -2.06
F-Score2
WACC7.86%
ROIC/WACCN/A
Cap/Depr(3y)254.9%
Cap/Depr(5y)225.76%
Cap/Sales(3y)387.17%
Cap/Sales(5y)479.05%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)27.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%18.18%
EPS Next Y-1.36%
EPS Next 2Y9.4%
EPS Next 3Y15.01%
EPS Next 5Y20.32%
Revenue 1Y (TTM)496%
Revenue growth 3Y63.16%
Revenue growth 5Y28.31%
Sales Q2Q%N/A
Revenue Next Year481.22%
Revenue Next 2Y248.71%
Revenue Next 3Y180.05%
Revenue Next 5Y122.11%
EBIT growth 1Y-37.18%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-8.92%
EBIT Next 3Y3.62%
EBIT Next 5Y24.14%
FCF growth 1Y-118.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-107.04%
OCF growth 3YN/A
OCF growth 5YN/A

AUTOLUS THERAPEUTICS PLC / AUTL FAQ

What is the fundamental rating for AUTL stock?

ChartMill assigns a fundamental rating of 3 / 10 to AUTL.


Can you provide the valuation status for AUTOLUS THERAPEUTICS PLC?

ChartMill assigns a valuation rating of 0 / 10 to AUTOLUS THERAPEUTICS PLC (AUTL). This can be considered as Overvalued.


Can you provide the profitability details for AUTOLUS THERAPEUTICS PLC?

AUTOLUS THERAPEUTICS PLC (AUTL) has a profitability rating of 1 / 10.